Newer Positive Inotropic Agents in the Treatment of Chronic Cardiac Failure
- 1 May 1987
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 33 (5) , 503-519
- https://doi.org/10.2165/00003495-198733050-00005
Abstract
No abstract availableKeywords
This publication has 63 references indexed in Scilit:
- Systemic and regional hemodynamic effects of captopril and milrinone administered alone and concomitantly in patients with heart failure.Circulation, 1985
- Beta-adrenergic stimulation of the failing ventricle: a double-blind, randomized trial of sustained oral therapy with prenalterol.Circulation, 1984
- Long-term hemodynamic effects of prenalterol in patients with severe congestive heart failure.Circulation, 1984
- Sustained improvement of cardiac function in patients with congestive heart failure after short-term infusion of dobutamine.Circulation, 1984
- Evaluation of a New Bipyridine Inotropic Agent — Milrinone — in Patients with Severe Congestive Heart FailureNew England Journal of Medicine, 1983
- Effect of hydralazine on perfusion and metabolism in the leg during upright bicycle exercise in patients with heart failure.Circulation, 1983
- Sustained hemodynamic and clinical effects of a new cardiotonic agent, WIN 47203, in patients with severe congestive heart failure.Circulation, 1983
- Decreased Catecholamine Sensitivity and β-Adrenergic-Receptor Density in Failing Human HeartsNew England Journal of Medicine, 1982
- Decreased Lymphocyte Beta-Adrenergic-Receptor Density in Patients with Heart Failure and Tolerance to the Beta-Adrenergic Agonist PirbuterolNew England Journal of Medicine, 1981
- Hemodynamic Assessment of AmrinoneNew England Journal of Medicine, 1978